Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.Pharmacoepidemiology and Drug Safety|April 14, 2015
Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure eventsVincent Lo Re, Dena M Carbonari, Kimberly A Forde, et al.Open Forum Infectious Diseases|April 30, 2025
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory CytokinesErica J Weinstein, Dean M Carbonari, Craig W Newcomb, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2019
Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular CarcinomaJessie Torgersen, Tamar H Taddei, Lesley S Park, et al.Gastroenterology|March 4, 2015
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care systemDavid S Goldberg, Kimberly A Forde, Dean M Carbonari, et al.Open Forum Infectious Diseases|September 29, 2025
Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral TherapyVincent Lo Re, Dean M Carbonari, Craig W Newcomb, et al.Journal of Hepatology|August 1, 2021
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensationJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 13, 2020
Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular CarcinomaJessie Torgersen, Michael J Kallan, Dena M Carbonari, et al.Pageof 8